Skip to main content

SKYX Signs a Licensing Agreement for Its Advanced Technologies with U.S., Canada, and Global Leading Lighting Company Eurofase

The New Licensing Agreement Expands SKYX’s Go-To-Market Channels as It Continues to Grow Its Market Penetration with Builders, Hotels, and Retail Segments  Eurofase Operates Globally with a Manufacturing and Distribution Network Spanning U.S., Canada, Europe, and Asia with Advanced Lighting Applications for Buildings, Hotels, Residential and Commercial Segments SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues through Interchangeability, Upgrades, AI Services, Monitoring, Subscriptions, Among Others MIAMI, May 20, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced smart home and AI platform technology company with over 100 U.S. and global pending and issued patents and a portfolio...

Continue reading

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade

Plans to File CTA for Ph. 1b, FIH Study, 30 – 40 Advanced Cancer Patients in ‘26 MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that the Company’s CEO, Mr. James Nathanielsz, forecasts new medical breakthroughs in the fight against pancreatic cancer over the next decade. Recent developments in treatment reflect a level of progress that has been difficult to achieve in this field. Clinical stage companies like Revolution Medicines Inc. and Erasca Inc. have demonstrated significant advancements in this field. New clinical data from a late-stage trial targeting KRAS mutations, which are present in many pancreatic...

Continue reading

Silynxcom Secures Order from European Army, Marking Entry into Additional European Market

Netanya, Israel, May 20, 2026 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, announced today that it has received a purchase order from an Eastern European army for its tactical communication systems. The order includes a range of Silynxcom’s field-proven tactical communication products, selected to meet the operational requirements of modern ground forces. “This order reflects the growing international recognition of Silynxcom’s ability to deliver reliable, mission-critical communication solutions that enhance operational effectiveness and soldier safety,” said Nir Klein, CEO of Silynxcom. “We are proud to be chosen by this European army and view this as an important milestone in...

Continue reading

Statement re Election of Home Member State

MAXIMA GRUPĖ, UAB (hereinafter – the Company), legal entity code: 301066547, registered office address: Ozo str., Vilnius, Lithuania. The total nominal value of the issued notes of the Company: EUR 350,000,000; ISIN code: XS3366323072. The Company hereby discloses that it elected Ireland as its Home Member State in accordance with the requirements of and for the purposes of Transparency Directive 2004/109/EC.

Continue reading

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity

Discussion highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to address limitations of current therapies Segment also discusses evolving treatment landscape, immunologically “cold” tumors and the future potential of off-the-shelf cell therapy approaches Access the segment here CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the release of a Virtual Investor KOL Connect segment featuring Dr. Elena Ratner, Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine and a member of Ernexa’s Board of Directors.  As part of the segment, Dr. Ratner discusses ovarian cancer, one of...

Continue reading

Lakeland Fire + Safety Delivers Head-to-Toe Fire Gear Order for Whitfield County Georgia Fire Department

New Customer Validates Ability to Deliver Integrated, Head-to-Toe Protection at Scale Lakeland Releases New Video of Interview with Whitfield Fire Chief and Assistant Chief at FDIC HUNTSVILLE, Ala., May 20, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced the delivery of an order for structural fire gear, rescue gear, structural helmets, hoods and gloves to the Whitfield County Georgia Fire Department. Terms of the orders were not disclosed. Whitfield County is south of Chattanooga and is home to the towns of Dalton, Tunnel Hill, Cohutta, and Varnell. The Fire Department serves the citizens of Whitfield County with a combination...

Continue reading

Orion to Host Q4 and Full Fiscal Year 2026 Investor Call Thursday, June 4, at 10 a.m. ET

MANITOWOC, Wis., May 20, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electrical vehicle charging station, and maintenance services solutions, will host a conference call and webcast to review its fiscal 2026 full fiscal year and fourth quarter results on Thursday, June 4, 2026, at 10:00 a.m. ET. Orion will release its results prior to the market’s opening that morning.Webcast and Call DetailsDate / Time: Thursday, June 4, at 10:00 a.m. ETLive Call Registration: https://register-conf.media-server.com/register/BI83b6ae45a1654d28babfa53b6617f6cc   Live call participants must pre-register using the URL above to receive the dial-in information. Anyone can re-register if they lose the dial-in or PIN #.Webcast & Replay: https://edge.media-server.com/mmc/p/zmyzetzn   About...

Continue reading

Foresight Moves to Serial Production with $10.5 Million Potential Revenue Pipeline in Japan for ADAS Systems

Revenues are based on a software license model with a high gross margin yield  NESS ZIONA, Israel, May 20, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced the signing of a Final Development and Commercialization Agreement with a Japanese in-vehicle AI device manufacturer (the “Manufacturer”) and Cornes Technologies Limited (“Cornes”) for the integration and deployment of Foresight’s proprietary ScaleCam™ stereoscopic 3D perception software into the Manufacturer’s flagship in-vehicle AI systems (the ”Agreement”). The Agreement, which includes a design freeze and transfer to production phase, paving the way to serial production in early 2027, is expected to generate a potential revenue, based on a software...

Continue reading

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

– Surgical Implant – Next Generation contract makes Symvess more easily accessible to 170 VA hospitals – – SAC awards require intensive product and value analysis vetting by a surgical committee and streamline the approval process by individual hospitals – DURHAM, N.C., May 20, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that Symvess is now under contract with the with Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs (VA). The SAC SING (Surgical Implant – Next Generation) contract makes Symvess more easily accessible to 170 VA hospitals as the SAC system is the preferred and primary sourcing vehicle for VA hospitals. SAC awards...

Continue reading

Duke Robotics Reports First Quarter 2026 Financial Results and Provides Business Update

Expansion of Israel Electric Corporation IC Drone Contract Expected to Generate Over $1 Million in 2026 Revenue Launch of AEROTRACE™ AI-Powered Aerial Intelligence Platform; Bird of Prey Defense Drone Collaboration with Elbit Continues to Advance as Global Defense Spending on Drone Tech Rises Subsequent to Quarter End, Company Completed Approximately $9.2 Million Underwritten Public Offering and Uplisting on the Nasdaq Capital Market FT. LAUDERDALE, FL, May 20, 2026 (GLOBE NEWSWIRE) — Duke Robotics Corp. (Nasdaq: DUKR; DUKRW) (“Duke Robotics” or the “Company”), a leader in advanced robotics and drone-based solutions for civilian and defense markets, today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update. Yossef Balucka, Chief Executive Officer of Duke Robotics, commented:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.